Please login to the form below

Not currently logged in
Email:
Password:

MK-3102

This page shows the latest MK-3102 news and features for those working in and with pharma, biotech and healthcare.

Merck & Co enters $430m diabetes deal with Abide

Merck & Co enters $430m diabetes deal with Abide

Merck also has a Januvia follow-up in development, with phase IIb data suggesting that MK-3102 could offer a similar level of effectiveness, but at a once-weekly rather than

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...